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Background: Offering the overweight or obese patient the option of choosing from a selection of weight loss diets
has not been investigated in type 2 diabetes. The aim of the study was to investigate if the option to choose from, and
interchange between a selection of diets (“Choice”), as opposed to being prescribed one set diet (“No Choice”),
improves drop out rates and leads to improved weight loss and cardio-metabolic outcomes.
Methods: The study was a 12 month, randomized parallel intervention. A total of 144 volunteers with type 2 diabetes
or pre-diabetes and a BMI >27 were randomized to “No Choice” or “Choice”. Those in the No Choice group were placed
on a set weight loss diet (CSIRO) with no change permitted. Those in the Choice group could choose from, and
interchange between, the CSIRO, South Beach or Mediterranean diets.
Results: There were no differences in attrition rates or weight loss between the “Choice” and “No Choice”. In a
secondary analysis of the intention-to-treat weight loss data with last measured weight carried forward gave a highly
significant diet group by time by gender interaction (p = 0.002) with men doing better in the No Choice group overall
(maximum difference “No Choice “-2.9 ± 4.6 kg vs. “Choice”-6.2 kg ± 5.3 kg at 6 months) and women doing better in
the Choice group overall (maximum difference Choice -3.1 ± 3.7 kg vs. “No Choice” -2.0 kg ± 2.6 kg at 6 months).
Conclusions: Men prefer direction in their weight loss advice and do less well with choice. A gender-specific approach
is recommended when prescribing weight loss diets.
Trial registration: anzctr.org.au ACTRN12612000310864.
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The diagnosis of obesity-associated type 2 diabetes can re-
duce a person’s life expectancy by 8-10 years [1] and qual-
ity of life, particularly as a result of complications [2,3].
However, morbidity and mortality related to diabetes can
be attenuated by a 15 - 20% reduction in body weight [1].
It is also possible, through lifestyle interventions, to pre-
vent or delay the development of diabetes in ‘at risk’ indi-
viduals with pre-diabetes [3].* Correspondence: Leah.Coles@bakeridi.edu.au
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unless otherwise stated.Lack of adherence to the weight loss plan prescribed is
one of the challenges when recommending dietary modifi-
cations to free-living individuals. In dietary interventions,
compliance and motivation of the participant generally de-
crease over time, regardless of the dietary regimen pre-
scribed [4,5]. Changing a dietary pattern when it is either
failing or because of boredom may produce a better result
than forcing the participant to persist with the same pat-
tern or drop out. Behavioural choice theory suggests that
patients who receive the treatment that they prefer will
have better outcomes in the context of a behavioural
modification [6]. In chronic conditions, and particularly
with regard to dietary modifications, the involvement and
preferences of the patient may be particularly importanttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Baseline characteristics for all participants who
enrolled in a 12 month weight loss trial1
Diet group
All (n = 144) No Choice (n = 73) Choice (n = 71)
Age (years) 58.3 ± 7.4 58.5 ± 6.9 58.0 ± 7.9
Weight (kg) 100.7 ± 17.6 100.6 ± 18.6 100.7 ± 16.7
BMI (kg/m2) 34.9 ± 5.4 35.0 ± 5.5 34.9 ± 4.8
HbA1c (%) 7.1 ± 1.3 7.1 ± 1.2 7.2 ± 1.4
Pre-diabetes (n=) 24 11 13
Diabetes (n=) 120 62 58
Male (n=) 78 38 40
Female (n=) 66 35 31
1Data are means ± SD.
There was no significant difference between participants in the Choice versus
the No Choice group for any variable or characteristic using one-way ANOVA.
HbA1c: glycosylated haemoglobin.
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lifestyle changes. Normal clinical practice is rarely as
flexible as this with few practitioners endeavouring to de-
termine patient needs and likes but we believe this is es-
sential for long term success. Few lifestyle intervention
studies have investigated choice or preference of treatment
in terms of obesity and they have mostly been short in dur-
ation or small in size. In a small pilot study, Murray [7]
found no differences between the group who received their
preference and those who did not. Similarly, Renjilian
found no difference comparing those who received their
preferred treatment (group or individual therapy) for obes-
ity and group therapy was far more successful [8]. It is pos-
sible in this study that the power of group therapy trumps
the loss of choice. In contrast to the behavioural choice the-
ory, Burke et al. in a large 18 month study found that those
who received their preference had less weight loss than
those who did not [9]. A larger two year study by Borridale
et al. [10] found that those who did not receive their prefer-
ence did significantly better than those who did. No gender
effects were explored. Thus overall the literature would
suggest that choice has either no effect or counterintuitively
leads to worse outcomes in obesity trials. This may relate to
the reasons people have become obese in which free choice
is clearly detrimental.
No dietary preference weight loss studies have been per-
formed dealing specifically with diabetes or pre–diabetes.
To our knowledge there have also been no dietary inter-
vention studies investigating preference of treatment that
have allowed subjects to change diets during the interven-
tion. Weight loss is greater in men than in women in most
studies, including those in people with type 2 diabetes
[11]. In the present work, we conducted a 12 month
weight loss study in people with diabetes and pre-diabetes
with the hypothesis that giving the participant the ability
to choose from and interchange between a selection of di-
ets, as opposed to being prescribed a set diet throughout,
will (i) reduce dropout rates, and (ii) lead to improved
weight loss and cardio-metabolic outcomes. We expected
men would lose more weight than women and that weight
loss would be greater with dietary choice in both groups.
Methods
Subjects
A total of 144 volunteers with a prior diagnosis of type 2
diabetes or pre-diabetes (self-reported as diagnosed by a
physician) aged 40 – 75 y and a current BMI >27 kg/m2
were recruited, primarily using advertisements in a dia-
betes magazine and the daily newspaper. Potential partici-
pants were posted a brief summary of the principles of
each of the three diets and were further able to view the
diet plans during a pre-enrolment information session
where they were told that all three diets had been shown
to be effective in weight loss, with no bias towards anyone diet. At the information session, participants gave
consent and selected their diet of choice should they be
randomly allocated to the Choice group. At the baseline
visit they were given full dietary information for the
CSIRO diet (No Choice group) or the diet that they had
earlier selected. Informed written consent was obtained
from all volunteers, and the study was approved by the
Alfred Health Human Ethics Committee (24/11).
Subjects on any medication for type 2 diabetes, includ-
ing insulin, were considered eligible. Exclusion criteria
were prior gastric surgery for weight loss, already follow-
ing a weight loss diet, taking appetite-altering drugs, or
an unwillingness to adhere (e.g. they only wanted to fol-
low one particular diet if enrolled in the study) to one or
more of the experimental diets for 12 months (excluding
short periods of up to three days). Subject characteristics
are given in Table 1.
Study plan
The study consisted of a 12 month parallel dietary inter-
vention (May 2011 to October 2012). Subjects were ran-
domized by random number generated using computer
software (Excel 2007, Microsoft Corporation, Redmond,
WA) to either the “No Choice” or “Choice” group after
consenting to participate with an allocation ratio (Choice:
No Choice) of 1 : 1.03. All enrolment procedures (random
number generation, participant enrolment and assignment
to one of the two groups) were undertaken by one or
more of the researchers using an identical procedure to
ensure consistency. Those allocated to the Choice group
(n = 71) could choose which of the three study diets they
wanted to follow and were able to seek permission from
the research team to switch between these diets at any
time. Those in the No Choice group (n = 73) were placed
on the CSIRO diet without any option to change diets.
Dietary advice was given by an Honours student and a
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knowledge transfer about the diet composition as well as
motivation was explored in the diet sessions. Behavioural
issues such as snacking and alcohol use which would be
common to all diets were explored.
Primary outcomes were weight and HbA1c. Secondary
outcomes were fasting glucose, triglycerides, cholesterol
(total, HDL and LDL) and high sensitivity c-reactive pro-
tein (hs-CRP) measured at baseline, 3 months, 6 months
and 12 months using venous fasting blood samples.
Weight (Model: Well-being, A&D Company Limited,
Tokyo, Japan), blood pressure (BP) (OMRON Automatic
Blood Pressure Monitor, Model HEM-907, OMRON Cor-
poration, Kyoto, Japan) and height (using a stadiometer)
were recorded at baseline. In between the baseline and
3 month visits, participants met with a member of the re-
search team fortnightly, with only weight and BP recorded.
At these fortnightly visits, further dietary advice was pro-
vided to all participants during a one-on-one 20 minute
consultation. Participants were encouraged by the research
team to return to the clinic to be measured regardless of
whether they complied with any dietary protocol. For the
remainder of the study (excluding the 3, 6 and 12 month
visits), visits increased to 6 weeks apart and changed to
researcher-led group sessions of an hour in duration cov-
ering nutrition education (e.g. interpreting nutrition infor-
mation on food labels) and behavioral issues with regard
to weight loss and weight maintenance. There was no seg-
regation of participants by diet group allocation (‘No
Choice’ or ‘Choice’) or diet (CSIRO, SB, MED) for these
group sessions. All data was collected onsite at Baker IDI
Heart & Diabetes Institute, Melbourne, Australia.
Physical activity
At the commencement of the study, participants were
provided with a basic pendulum pedometer (Be Active
Step by Step, Model WWA2026, Pedometers Australia,
Cannington, WA, Australia) and log book to record daily
step count as motivation to follow the research team’s rec-
ommendation of least 30 min of physical activity (PA)
most days [12]. A self-report questionnaire about PA pat-
terns (type of PA, frequency and duration) was completed
by participants at baseline and 12 months.Diets
The three experimental diets were designated: South
Beach (SB) [13], Mediterranean (MED) and The CSIRO
Total Wellbeing Diet (CSIRO) [14]. Main features of the
three interventional diets are provided as supplementary
information for comparative purposes (Additional file 1).
When followed as prescribed, the CSIRO and MED diets
provided approximately 6000 kJ/day for both men and
women, whilst the SB diet was ad libitum.The SB and CSIRO diets were prescribed as published
[13,14], whilst the MED diet was based on that described
by Shai et al. [15] with the following guidelines: 3 servings
of fruit and 4 servings of vegetables daily, 2 servings each
of olive oil (1 serving = 1 teaspoon), whole grains and dairy
daily, 3 servings of nuts and 2 servings of legumes weekly,
optional daily intake of red wine with meals (1 × 80 ml
glass for women and 1 - 2 for men), and red meat no more
than once per week, with poultry (2 - 4 servings weekly)
and fish/shellfish (2 servings weekly) being the main
sources of protein. Participants were given documentation
explaining their diet plan including appropriate recipes.
Participants in the ‘No Choice’ group were only given in-
formation on the CSIRO diet and similarly, ‘Choice’ partic-
ipants were only given information on their selected diet.
There was no expectation from previous trials that there
would be any difference in weight loss between the diets
as low carbohydrate, low fat and Mediterranean style diets
have all been shown to be equally as effective in terms of
weight loss over two years [15]. Our primary hypothesis
was that Choice (regardless of actual diet chosen) would
lead to better outcomes than No Choice.
Chemical analyses
Venous blood samples were analyzed for glucose, glycosyl-
ated haemoglobin (HbA1c), cholesterol (total, HDL, LDL),
total triglycerides and hs-CRP. Glucose (hexokinase
method), cholesterol (enzymatic method), triglycerides (gly-
cerol phosphate oxidase method) and hs-CRP (immunotur-
bidimetric method) were analyzed on an Archicentre
ci16200 (Abbott Laboratories, Abbott Park, IL). HbA1c
(Boronate Affinity HPLC method) was analyzed on a Pri-
mus CLC-385 (Primus Diagnostics, Kansas City, MO).
Statistical analysis
A power analysis indicated 70 participants would be
needed (35 per group completing) to provide 80% power
to detect a 1.5 kg difference between Choice and No
Choice at a significance level of 0.05 with a standard de-
viation of 2.2 kg. To account for withdrawals and loss to
follow-up over 12 months the aim was to recruit at least
120 participants. The standard deviation was based on
our own published weight loss studies. The difference of
1.5 kg chosen was based on the difference seen between
the treatment incongruent group and the no strong pref-
erence group from Borradaile et al (10)”.
Repeated measures ANOVA was performed on weight at
baseline, 3, 6 and 12 months (SPPS version 19.0, IBM
Corp., Armonk, NY) on an ‘intention-to-treat’ (ITT) basis
using last measured weight carried forward for non-
completers and in a second analysis with the addition of
1 kg increase per 12 months, with ‘Choice’ or ‘No Choice’
as the primary dietary factor and gender as a second factor.
Secondary analyses were change of diet (yes/no) and
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subjects in Choice and No Choice were compared using
one-way ANOVA. Changes in baseline cardio-metabolic
measures at 12 months for completers were analyzed using
repeated measures ANOVA. Retention rates, difference in
physical activity levels and group session attendance rates
between diet groups were also assessed by Chi-squared
analysis. Medication changes (none, decreased or in-
creased) were analyzed by univariate ANOVA. Correla-
tions between group session attendance and weight loss
were determined using a Pearson’s Correlation. A value
of p < 0.05 was accepted as significant in all cases. Data
are shown as mean ± SD, error bars are ± SE.
Results
Baseline characteristics of all subjects (n = 144) are given
in Table 1. There was no significant difference between
participants in the Choice versus No Choice group in
terms of baseline age, weight, HbA1c or BMI for these
participants, nor for the cohort (n = 96) that completed
the entire trial (data not shown). A CONSORT-style
flow chart detailing numbers of participants at enroll-
ment, allocation, follow-up (3, 6 and 12 months) and
analysis is shown (Figure 1).Weight changes at 12 months
There was no significant difference between weight loss
for the 12 month completers in the No Choice (-3.5 ±
4.5 kg or -3.4 ± 4.5%) and Choice (-2.7 ± 5.0 kg or -2.8 ±
4.8%) arms over time. Weight change (kg) as categorized
by diet group (Choice or No Choice) and gender over
time is given both for 12 month completers (Figure 2A)
and all enrolled participants on an ITT basis (Figure 2B).
There was no significant effect of gender on weight loss
in either the completers or the full cohort (ITT). Ana-
lysis of the ITT weight change (kg) data gave a highly
significant diet group by time by gender interaction (p =
0.002) with men doing better in the No Choice group
(maximal difference -2.9 ± 4.6 kg vs. -6.2 kg ± 5.3 kg at
6 months) and women doing better in the Choice group
(maximal difference-3.1 ± 3.7 kg vs. -2.0 kg ± 2.6 kg at
6 months). In men alone, there was a significant effect
of diet group allocation (Choice or No Choice) over time
on absolute weight loss (p = 0.001). Even with the same
diet (CSIRO) men on No Choice did better (weight loss
of 4.6 kg versus 2.4 kg for those in Choice), although
this was not statistically significant (p = 0.17) because of
the small sample size. There were no differences in
women alone. After removal of the SB diet from these
two analyses (n = 135 in the analysis), there remained a
significant diet by time by gender interaction on weight
loss (p < 0.05) and a significant effect (p = 0.007) in men
alone on weight loss.In another analysis in which 1 kg per year weight gain
(or fractions thereof) were added to the weight loss of the
dropouts the diet group by gender by time remained sig-
nificant (p = 0.02). In men alone the difference was still
significant overall with an adjusted 12 m weight loss differ-
ence of 4.1 kg in No Choice vs 1.5 kg Choice (p = 0.02).
If you analyse without those in the No choice group
who got their desired CSIRO diet which removes 31 in-
dividuals there was still a diet by time by gender inter-
action (p = 0.03). If you remove those who didn’t get
their preferred diet which removes 41 individuals there
was still a diet by time by gender interaction (p = 0.02).
Diet selection
Of the 71 participants who were allocated to the Choice
group, 34 chose CSIRO, 26 chose MED and 11 chose SB
at baseline (Figure 1). Due to the fact that participants
were asked to select their diet preference before they were
allocated to the Choice or No Choice group, it was pos-
sible to determine how many participants received their
diet preference and also determine if there was a gender
preference in the overall group. Of the people who were
placed in the No Choice group, 24 had selected MED and
19 had selected SB as their diet preference. As such, just
under half (41%) of the 73 participants in the No Choice
group were placed on their diet of preference (CSIRO),
compared to 48% of participants in the Choice group who
chose CSIRO diet and would therefore have been given
their diet of preference even if they had instead been
placed in the No Choice group. There was no significant
difference between diet groups regarding those who chose
CSIRO and those who did not. There were significant (p <
0.05) gender differences between diet preferences (prior to
diet group allocation) when comparing the proportion of
males and females who selected SB versus MED, SB versus
CSIRO and CSIRO versus MED. Men favored SB (9 f,
21 m) and MED (22 f, 29 m) whilst women favored
CSIRO (35 f, 28 m). These gender ratios were similar to
those for participants who were actually placed in the
Choice group, i.e. women favored the CSIRO diet (19 f,
16 m), whilst the MED diet (9 f, 15 m) and SB diet (2 f,
9 m) were more popular amongst men, although differ-
ences in gender proportions were only significant for SB
relative to the two other diets (p < 0.05).
Diet changes
Only five participants in the Choice group changed diets
during the study: two from MED to CSIRO, one from
MED to SB, one from CSIRO to SB and one from
CSIRO to MED (Figure 1). All diet changes occurred be-
tween 8 – 20 weeks and in all but one case, only women
opted to change diets. Study staff were not aware of any
participant in the No Choice group attempting to follow
any diet plan other than CSIRO (i.e. had changed diets)
Figure 1 CONSORT-style flow chart.
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ged to another Choice diet without the prior knowledge
of study staff. This was based on frequent questioning of
participants by study staff during check-ups.Retention rates
Of the 144 participants at baseline, those remaining in
the trial at key milestones were: 122 participants (85%)
at 3 months, 112 participants (78%) at 6 months and 96
Figure 2 Weight change (kg) from baseline by diet group and
gender. A. Shows only those participants who completed the
12 month weight loss program. B. Shows weights for all participants
enrolled at baseline with weights carried forward from last known
measurement for participants who discontinued the weight loss
program. Data are means, error bars represent SE. P-values determined
using repeated measures ANOVA. Participant numbers were: A. No
Choice – women (n = 21) and men (n = 28); Choice - women (n = 18)
and men (n = 29); and B. No Choice – women (n = 35) and men
(n = 38); Choice women (n = 31) and men (n = 40).
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rates (at 12 months) were similar for subjects with pre-
diabetes (67%) and type 2 diabetes (68%). Although a lar-
ger number of men (73%) compared to women (59%)completed the trial, the gender difference was not sig-
nificant. There was no instance of participant withdrawal
due to a participant being randomly allocated to Choice
(when No Choice was preferred) or No Choice (when
Choice was preferred). Retention rates by allocated group
(Choice and No Choice) were comparable (Choice: 66%,
No choice: 67% at 12 months) with no significant differ-
ence between Choice and No Choice at 3, 6 or 12 months
(p > 0.05). The withdrawal rate from the SB diet was sig-
nificantly higher than for the other diets at 3 months (p <
0.05) with 4 out of the 11 subjects withdrawing in the first
12 weeks. Of the five withdrawals from SB, three were due
to the participant not achieving their weight loss or health
goals, which was not a common reason for withdrawal
from the other diets (only two other participants gave this
as a reason for withdrawal - both in the No Choice group).
The most common reason for non-completion, generally,
was due to work and/or travel commitments, making it
difficult for participants to attend appointments during
the study and/or to follow the prescribed diet. Because of
the difficulties with the SB diet we have done a separate
analysis excluding participants who chose this diet.
Physical activity changes
Of the 96 completers, complete baseline and 12 month
self-report data on physical activity (PA) was provided by
78 subjects (Choice n = 38, No Choice n = 40). For these
78 participants, an assessment was made of whether the
participant was meeting the recommended [12] 150 min
of physical activity per week at baseline and/or 12 months.
At baseline, 52 participants (67%) were meeting PA guide-
lines, with no significant difference between the propor-
tion in the Choice (68%) versus No Choice group (65%).
At 12 months, 49 participants (65%) were meeting PA
guidelines, with no significant difference between propor-
tions in the Choice (61%) versus No Choice group (65%).
Medication changes
A total of 19 participants (11 ‘Choice’ and 8 ‘No Choice’)
had changes to diabetes medication (increase or decrease)
during the study at the instruction of the participant’s
physician (or the physician within the research team, who
was blinded to the participant’s diet group, on a case by
case basis as required). Approximately half of these partic-
ipants (ten in total) were taking only oral diabetes medica-
tion, whilst the remainder were taking insulin exclusively
or in combination with oral diabetes medication. With the
exception of five participants (3 ‘No Choice’), all changes
were a decrease in diabetes medication. Multiple diabetes
medication reductions occurred for five participants,
whilst four participants ceased all diabetes medication
during the study, including one participant who was tak-
ing insulin at baseline. Change in body weight at
12 months (relative to baseline) was borderline significant
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medication changes (-2.4 kg weight change), diabetes
medication reductions (-4.4 kg) or increases (1.8 kg).
Group session attendance
Attendance rates at the four group dietary counselling ses-
sions for the participants completing the 12 month pro-
gram varied from 25% (one session) to 100% (four
sessions) (Additional file 2). In both the Choice and No
Choice groups, 100% attendance was evident in 40% of the
group. There was no effect of group session attendance on
weight loss for the 12 month completers when this was
added as a covariate in the repeated measures ANOVA.
However, there was a correlation between group session at-
tendance and weight change (r = 0.21, p = 0.038).
Cardio-metabolic changes
Changes in HbA1c (%), fasting glucose, triglycerides, chol-
esterol (total, LDL and HDL) and hs-CRP at 12 months
relative to baseline are given in Table 2. Importantly, there
was no significant difference for participants in the Choice
group relative to those in the No Choice group at
12 months. However, there was an overall effect of time
on fasting glucose (p = 0.02), diastolic (DBP) (p = 0.02) and
systolic BP (SBP) (p < 0.001).
Discussion
Lifestyle interventions frequently require considerable ef-
fort and long-term commitment by the individual and
their effectiveness is often hindered by lack of adherence.
The present study investigated whether patient freedom to
choose a weight loss diet and later change to a different
diet (if desired) would lead to increased weight loss and/or
improvements in HbA1c .Table 2 Cardio-metabolic changes from baseline to 12 months
Variable
All (n = 96)
Baseline change
SBP (mmHg) 140.8 ± 18.1 −6.4 ± 17.4§
DBP (mmHg) 84 ± 10.8 −3.9 ± 10.8§
HbA1c (%) 7.02 ± 1.26 −0.15 ± 0.79
Fasting Glucose (mmol/L) 7.47 ± 2.28 −0.42 ± 1.75§
Triglycerides (mmol/L) 1.79 ± 0.89 −0.09 ± 0.89
Total cholesterol (mmol/L) 4.50 ± 1.13 −0.01 ± 0.61
HDL cholesterol (mmol/L) 1.20 ± 0.45 −0.05 ± 0.35
LDL cholesterol (mmol/L) 2.46 ± 1.01 0.12 ± 0.61
hs-CRP (mg/L) 2.96 ± 2.45 −0.36 ± 1.84
1Data are means ± SD, shown only for those participants who completed the 12 mo
§There was no effect of diet group for any variable (repeated measures ANOVA), and no
variable for any diet group (All, No Choice or Choice) except for change in overall SBP (p
DBP: diastolic blood pressure, HbA1c: glycosylated haemoglobin, HDL: high-density
tein, SBP: systolic blood pressure.Participants in the choice group rarely changed diets
The fact that only five participants in the Choice group
elected to change diets was an unexpected outcome and
an important finding given the ability to change diets dur-
ing a weight loss intervention has not been investigated
previously. Instead of changing diets, participants not
achieving their weight loss or health goals preferred to
withdraw entirely from the study. This may have been be-
cause participants in the Choice group had already chosen
the diet that they viewed as most likely to give them suc-
cess or that participants in the Choice group had an in-
flated expectation of success compared to those in the No
Choice group. The latter is consistent with other lifestyle
intervention studies where participants who had the ability
to select diets performed poorly compared to those who
did not [10, 16]. In the present study, there was no signifi-
cant difference in Choice and No Choice groups with re-
spect to withdrawal rates or the proportion of participants
in each group who received their diet of choice.
Gender differences in diet preference, attrition rates and
weight loss
Overall, males were well represented in the study and out-
numbered the women. A key finding in the present study
was the gender differences that existed with relation to
dietary preference in terms of diet selection and weight
loss outcomes.
Gender differences in initial diet preference
The strong male bias towards SB may have been due to a
preference for animal protein amongst men, its simplicity
(all foods were designated as ‘allowed’ or ‘not allowed’) or
non-calorie restricted design. Men, however, coped poorly
with this diet and either dropped out or had poor weightfor participants completing a 12 month weight-loss trial1
Diet group
No Choice (n = 49) Choice (n = 47)
Baseline change Baseline change
142.9 ± 19.5 −6.7 ± 17.5 138.5 ± 16.6 - 6.2 ± 17.4
85.0 ± 11.4 −5.0 ± 10.1 82.7 ± 10.2 −2.7 ± 11.6
7.04 ± 1.28 −0.19 ± 0.82 6.99 ± 1.26 −0.11 ± 0.77
7.51 ± 2.50 −0.53 ± 1.94 7.41 ± 1.93 −0.31 ± 1.53
1.85 ± 0.97 −0.26 ± 0.76 1.73 ± 0.79 0.09 ± 0.98
4.33 ± 0.94 −0.05 ± 0.60 4.67 ± 1.29 0.03 ± 0.63
1.13 ± 0.24 −0.01 ± 0.16 1.28 ± 0.59 −0.09 ± 0.47
2.26 ± 0.89 0.15 ± 0.68 2.66 ± 1.10 0.08 ± 0.52
3.15 ± 2.72 −0.51 ± 2.13 2.76 ± 2.14 −0.21 ± 1.49
nth trial.
significant difference between baseline measures and those at 12 months for any
< 0.001), DBP (p = 0.02) and fasting glucose (p = 0.02) (repeated measures ANOVA).
lipoprotein, hs-CRP: high-sensitivity c-reactive protein, LDL: low-density lipopro-
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that men did worse with choice. Women strongly pre-
ferred CSIRO. Other studies have shown that women are
more likely to sacrifice their dietary regimen for their
family’s food preference [17] and CSIRO was viewed by
many participants as being ‘family friendly’. It is plausible
that the women in our study, most likely responsible for
the nutrition of the household, took into greater account
the acceptability of the diet by other (particularly younger)
family members than the men did.
Gender differences in familial support
A recent study by Mathew et al. [18] highlights the strug-
gles with diet and nutrition among women in diabetes
self-management. Other previous work is consistent in
that women are supportive of their husband’s dietary
changes and diabetes self-management, whilst men are
less supportive of their wife in this regard [19,20]. Female
participants more often complained about the lack of fa-
milial support and family pressures, including their
family’s dislike at having to eat differently, which hindered
their own compliance.
Gender differences in weight loss
The observed diet group (Choice or No Choice) by time
by gender interaction suggests that both gender and its
interaction with the option to choose or not choose be-
tween weight loss diets are important determinants of
weight loss success. The results presented here support a
gender-specific approach when offering nutritional advice
for weight loss and diabetes management. Specifically, our
findings suggest that men may achieve better weight loss
outcomes when given a single option. Although our data
suggest that offering an array of options to men for weight
loss may not lead to the best outcome for the group,
clearly within the group there would be many men who
would welcome and do better with an array of choices.
Some practitioners would also not be comfortable offering
only one solution to men. The reasons for men to not do
as well with a choice of diets and the ability to change di-
ets is not clear but may relate to lack of confidence in
decision making about food and a lack of knowledge com-
pared with women. Dietary advice was given by an
Honours student and a Nutrition PhD. No dietetic profes-
sionals were used. Both knowledge transfer about the diet
composition as well as motivation was explored in the diet
sessions. Behavioural issues such as snacking and alcohol
use which would be common to all diets were explored
even when those in the No Choice group who received
their desired diet were removed from the analysis there
was still a diet by time by gender interaction ie the loss of
choice was the most important factor rather than the diet
per se. Although in experimental tests of decision making
with a variety of scenarios there are no differencesbetween men and women [21] but with patients surveyed
after an acute ischemic event men were reported to be
more satisfied with the information received while women
wanted more information although both agreed that only
a minority of decision making was shared although this is
what they both wanted. This suggests men were more
content with the reality of following doctors decision [22].
In weight loss studies once a man has made a decision
that weight loss is required (which they do much less often
than women) they are much more successful at achieving
weight loss regardless of the dietary intervention.
Limitations of the present study
This study was limited by a lack of diet records, mea-
sures of satisfaction and a lack of alternative diets in the
No Choice group to ensure no one in this group was
given their desired diet. Underlying personal traits or be-
haviors related to the type of diet a person chose may
have also effected their success in implementing behav-
ioral lifestyle changes (as opposed to the actual diet
plan). For example, people who enjoy cooking, previ-
ously shown to be a factor in successful weight manage-
ment [23], may have chosen CSIRO whilst people who
do not make good food choices may have preferred the
‘black and white’ rules of excluding carbohydrate in SB.
Some individuals may have lost considerable weight re-
gardless of the diet due to possessing a good support
network, or the necessary skills and behaviors likely to
lead to success. Despite the researchers’ best efforts to
be impartial, there may have been bias in the nutritional
counseling provided to one group (e.g. diet, gender, diet
group) over another. Participants themselves may have
had perceptions of what the best diet or diet group was
and this may have influenced or been influenced by
other participants during group sessions.
Conclusions
In conclusion, the option to change dietary patterns did
not improve retention rates in this weight loss interven-
tion, although gender differences exist in terms of diet
selection and weight loss outcomes. For men, clear dir-
ection was important. Current dietetic practice generally
places little emphasis on gender-specific approaches
when offering nutritional advice for weight loss and dia-
betes management. This is particularly pertinent in the
case of women with chronic physical medical conditions
who may be attempting to make lifestyle changes with-
out their family’s support or willingness to adapt to dif-
ferent dietary patterns. Prescribing a set weight loss
regimen to such a patient without consideration of such
familial obstacles is more likely to be ineffective and may
in fact contribute to the person’s low self-esteem (and
further weight gain) from repeated failed weight loss
attempts.
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